Login

Why an Expanding San Francisco Bay Area Biotech Firm Chose Philadelphia for Its East Coast Hub

Exelixis Shows How Secondary Life Science Markets Step Into Their Own With Surging R&D Space Demand
Life science startup activity in the Philadelphia area is forecast to surge as more companies look to the area as a cheaper alternative for biotech space. (iStock)
Life science startup activity in the Philadelphia area is forecast to surge as more companies look to the area as a cheaper alternative for biotech space. (iStock)
CoStar News
April 26, 2022 | 1:11 AM

It has roots in Boston and a recently expanded corporate headquarters in the San Francisco Bay Area, but life science firm Exelixis is planting a flag in the Philadelphia suburbs as demand for research and development space across the country fuels momentum in second-tier biotech markets.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE